Cargando…
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide
Molecular-targeted therapy has had a significant impact on glioma. Notably, actin-like 6A (ACTL6A) has been indicated to be essential for embryonic development and tumor progression. However, the role of ACTL6A in glioma remains unclear. The present study aimed to investigate the effects of ACTL6A o...
Autores principales: | Chen, Xueru, Xiang, Zijin, Li, Dangchi, Zhu, Xiuting, Peng, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792480/ https://www.ncbi.nlm.nih.gov/pubmed/33456542 http://dx.doi.org/10.3892/etm.2020.9606 |
Ejemplares similares
-
Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway
por: Xiang, Zijin, et al.
Publicado: (2020) -
GALNT6 Knockdown Inhibits the Proliferation and Migration of Colorectal Cancer Cells and Increases the Sensitivity of Cancer Cells to 5-FU
por: Peng, Xiangdong, et al.
Publicado: (2021) -
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018) -
Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC
por: Xiang, Zijin, et al.
Publicado: (2022) -
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma
por: Chen, Ling, et al.
Publicado: (2020)